Estimating the Economic Consequences of Migraine in Sweden: A Fiscal Model Using the Government Perspective of Costs

Author(s)

Martins R1, Jakobsson M2, Surmay G3, Connolly M4
1University of Groningen, Groningen, Groningen, Netherlands, 2Pfizer Innovations AB, Stockholm, Sweden, 3Pfizer Biopharmaceuticals Group, New York, NY, USA, 4Global Market Access Solutions, Groningen, GR, Netherlands

OBJECTIVES: Migraine is a serious neurological condition manifesting from early adulthood and predominantly affecting females. Migraine was reported to affect 13.2% of the Swedish population, approximately 1.1 million individuals. This analysis aims to estimate migraine economic burden to the Swedish government using a fiscal modelling framework.

METHODS: Migraine-related changes to productivity were estimated for a cohort affected by migraine and compared with a demographically identical cohort from the Swedish general population (GP). Relative measures of migraine’s impact on productivity were sourced from peer-reviewed publications and applied to the GP rates of unemployment, absenteeism, disability, and early retirement sourced from national statistics. Foregone labor, direct and indirect taxes, increased social benefit transfers, and healthcare costs were accrued from age 44 over a 20-year time horizon (longitudinal engine), or for the adult population affected by migraine in 2022 (cross-sectional engine), and reported as net monetary consequences. Longitudinal results were discounted at 3%.

RESULTS: The migraine cohort was affected by higher rates of absenteeism, unemployment, disability, and early retirement. Over 20-years, an average individual affected by migraine generated SEK464,867 in additional costs to the Swedish government, compared to a person in the GP. This was equivalent to SEK30,669 per year lived with migraine. The entire population affected by migraine was estimated to cost SEK33.9 billion in 2022 alone (0.4% of Swedish gross domestic product), an average of SEK25,153 per person with migraine. Healthcare costs connected to migraine represented 40-50% of the total economic burden from the longitudinal and cross-sectional results, respectively. Public sector migraine-related absence represented 26% of the economic burden, half of which was due to absenteeism among healthcare and social care workers.

CONCLUSIONS: Migraine was associated with important economic losses to the Swedish government. Decreased productivity and foregone tax revenue represented a minimum of 50% of the economic disease burden.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

EE659

Topic

Economic Evaluation, Health Policy & Regulatory, Study Approaches

Topic Subcategory

Decision Modeling & Simulation, Public Spending & National Health Expenditures

Disease

Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×